Global Tendinitis Treatment Market - 2022-2029

Global Tendinitis Treatment Market - 2022-2029

Market Overview

The Global Tendinitis Treatment Market is expected to grow at a high CAGR during the forecasting period (2022-2029).

Tendonitis is the inflammation of a tendon that happens when a person overuses or injures a tendon during sports or any other physical activity. It is linked to an acute injury with inflammation. It mostly affects the elbow, wrist, finger, thigh, and other body parts where tendons are present. The tendon is more fibrous and denser than the elastic, fleshy muscle. Tendinitis is more common among athletes and is one of the most prevalent sports injuries in sports players, especially in tennis, golf, and others.

Market Dynamics

The global tendinitis treatment market growth is driven by the increase in the prevalence of tendinitis, the introduction of new treatments and therapies, increasing awareness, and an increase in healthcare expenditure.

The increasing incidence of sports-related injuries will drive the market growth

The increasing incidence of sports-related injuries owing to the rapid increase in sports activities is the leading cause of soft tissue injuries worldwide and a main impact-rendering driver for the market. Moreover, growing career opportunities and rising inclination towards healthy fitness have increased the number of individuals adopting sports as a career or a hobby. It, in turn, is projected to increase their chances of incurring injuries. According to a study published by a group of sports medicine professors from the University of Virginia and Duke University, approximately 40.0% to 50.0% of the competitive runners have been witnessed to suffer from Achilles tendinopathy.

The increasing incidence of tendonitis in the general population accounting for approximately 5-10 cases per 100,000 individuals is further expected to drive the market for tendonitis treatment. Moreover, the growing penetration of various treatment options such as physical therapy, over-the-counter drugs for pain management, and different surgical procedures has increased the number of individuals undergoing treatment, thereby aiding the market growth. Among these, physical therapy has proved to be the first-line treatment for tendonitis because eccentric strengthening has been considered a very effective treatment for various chronic tendon conditions. These factors are driving the growth of the market in the forecast period.

The lack of awareness about the disease will hamper the growth of the market

However, a lack of awareness about the disease and its advanced treatments among the population may negatively affect the market. Currently used clinical grafts in tendon treatment are subjected to various restrictions and there is a significant demand for alternative engineered tissue. Owing to this, it is an aggressive need for innovative strategies such as tendon replacement and regeneration to sustain market growth.

COVID-19 Impact Analysis

After the COVID-19 pandemic, care delivery methods for treating tendonitis have altered. Due to temporary lockdowns, travel restrictions, and a high infection load on the healthcare sector, the market value was impacted negatively. The shortage of healthcare professionals for treating tendonitis restrained the development and growth of the market during the COVID-19 pandemic. The cancellation of sports activities resulted in fewer sports injuries, negatively impacting the tendonitis treatment market. The healthcare facilities and various elbow and shoulder surgeons worldwide are evaluating their perception of emergency, and are actively focused to predict the new normal with changed priority order for treatment procedures in the forthcoming post-COVID scenario, thereby providing affirmative growth prospects in the forecast period.

Segment Analysis

The tennis elbow segment is expected to grow at the fastest CAGR during the forecast period (2022-2029)

The tennis elbow segment has the largest share during the forecast period. New product launches and the availability of cost-effective treatment options are the major growth factors for the tennis elbow segment.

In a study titled, New Interventional Radiology Treatment for Tennis Elbow Reduces Pain and Inflammation Without Surgery, published in March 2019, 52 patients with tennis elbow who did not find relief from any other treatments were treated with Transcatheter Arterial Embolization (TAE) during 2013-2017 and followed up with for four years after the treatment. The study suggested that a statistically significant rate of pain relief among the patients was found. Images taken of 32 patients two years after undergoing TAE showed an improvement in tendinosis and tear scores. A study published in February 2019 titled Evidence-based Recommendations for the Management of Anterior Cruciate Ligament (ACL) Rupture stated that in the US alone, 250,000 individuals suffer an anterior cruciate ligament (ACL) rupture per year, commonly known as ligament tennis elbow. As the tennis elbow segment grows, treatment options are also increasing. Non-invasive therapies are used for tennis elbow treatment. However, the use of braces also gives relief to patients. As per an article published in April 2022 in Orthotexas, tennis elbow can be treated with a bracing program rather than surgery. Hence, major players are focusing on product innovations and boosting the segment’s growth.

The injuries due to ATVs, mopeds, and minibikes were 230,000, and those due to skateboards,scootersr, and hoverboards were 218,00, ranking third and fourth. The increasing number of injuries primarily contributes to the tennis elbow segment by condition. The growing number of sports injuries and the prevalence of the disease in the elderly population are driving the growth of the market.

Geographical Analysis

North America region holds the largest market share of the global tendinitis treatment market

North America dominates the market for tendinitis treatment and is expected to show a similar trend over the forecast period, due to the presence of major players and higher expenditure on advancements in healthcare. Awareness among people about the disease is growing more in North America compared to other regions.

According to data from the National Safety Council (NSC), about 130,000 swimming injuries were treated in emergency rooms in 2020, with children under 14 years suffering half of all injuries, according to data from the National Safety Council (NSC). This age group accounted for 45% of soccer injuries, 44% of baseball injuries, and 40% of lacrosse and rugby injuries, treated across emergency rooms in 2020. These increasing number of sports injuries and rising prevalence of diseases like tennis elbow, followed by an increased number of older people with tendonitis, are driving the market's growth in North America.

According to the annual data provided by the US Bureau of Labor Statistics for Employer-Reported Workplace Injuries and Illnesses in 2020, sprains, strains, and tears leading to tendonitis were 266,530, with 1,380 tendonitis patients in the US. Thus, these factors are driving the growth of the market in the region.

Competitive Landscape

The Tendinitis Treatment Market is a moderately competitive presence of local as well as global companies. Some of the key players which are contributing to the growth of the market include DJO Global Inc., Teikoku Pharma USA Inc., Zimmer Biomet, 3M, AKSIGEN, Smith+Nephew, Stryker, Ossur, Tynor India, Bayer among others. The major players are adopting several growth strategies such as product launches, acquisitions, and collaborations, which are contributing to the growth of the tendinitis treatment market globally. For instance, in December 2022, Delsson, an engineering firm in Singapore, in collaboration with 3D printing specialists from Nanyang Technological University (NTU), Singapore, developed the X-Brace, which is almost 30% lighter than traditional exoskeleton knee braces.

Bayer AG

Overview:

Zimmer Biomet Holdings, Inc., together with its subsidiaries, operates in the musculoskeletal healthcare business in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. The company designs manufacture, and markets orthopedic reconstructive products, such as knee and hip products; S.E.T. products, including sports medicine, biologics, foot and ankle, extremities, and trauma products; spine products comprising medical devices and surgical instruments; and face and skull reconstruction products, as well as products that fixate and stabilize the bones of the chest toss facilitate healing or reconstruction after open-heart surgery, trauma, or for deformities of the chest.

Product Portfolio:

Nexel Total Elbow: Zimmer Biomet’s Nexel Total Elbow builds upon the original, market-leading Coonrad/Morrey Total Elbow. Nexel Total Elbow offers proprietary Vivacit-E polyethylene bearings and advances in instrumentation

Why Purchase the Report?

Visualize the composition of the global tendinitis treatment market segmentation by condition, treatment, end-user, and region highlighting the key commercial assets and players.

Identify commercial opportunities in the global tendinitis treatment market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of global tendinitis treatment market-level 4/5 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key product of all major market players

The global tendinitis treatment market report would provide access to approximately 40+ market data tables, 45+ figures, and in the range of 190 (approximate) pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers